Primary Bladder Adenocarcinoma: A Case Report
Primary bladder adenocarcinoma (PBA) is rarely seen in the clinical setting at present. Bladder adenocarcinoma has a special biological behavior, as well as high invasive and metastatic potential. In addition, it is very difficult to diagnose PBA at an early stage. Having similar clinical manifestation to urothelial carcinoma and metastatic adenocarcinoma of the bladder, the differential identification and diagnosis have become more complicated. A majority of adenocarcinoma is not sensitive to radiation and chemotherapy, and thus, the prognosis of PBA is generally poorer. Currently, surgery serves as the principal mode of treatment. In this case report, we had observed a PBA case for 1.5 years, and no recurrence and metastasis had been reported.
Uhliga A, Behnesb CL, Strauss A, et al., 2018, Primary Bladder Adenocarcinoma: Case Report with Long-Termfollow-Up. Urol Case Rep, 18:64–6.
Na YQ, Ye ZQ, Sun YH, et al., 2014, Guidelines for Diagnosis and Treatment of Diseases in Chinese Urology. Beijing: People’s Medical Publishing House, pp.54.
Wang MR, Zhou HL, Gao BS, et al., 2016, Report of 2 Cases of Bladder Adenocarcinoma. Chin J Lab Diagn, 20:1776–7.
Xu HY, Wang DH, 2017, Advances in the Diagnosis and Treatment of Bladder Adenocarcinoma. Int J Urol Nephrol, 37:271–3.
Shi YX, Xie YH, Luo B, 2018, A Case of Urachus Adenocarcinoma. J Clin Exp Pathol, 34:468–9.
Quan J, Pan X, Jin L, et al., 2017, Urachal Carcinoma: Report of Two Cases and Review of the Literature. Mol Clin Oncol, 6:101–4.
Guo XX, Liu YH, Li WT, et al., 2018, Primary Adenocarcinoma of the Bladder: A Case Report and Literature Review. Asia Pac Tradit Med, 14:124–5.
Bruins HM, Visser O, Ploeg M, et al., 2012, The Clinical Epidemiology of Urachal Carcinoma: Results of a Large, Population Based Study. J Urol, 188:1102–7.
Willian S, Marta B, Marco F, et al., 2018, Urachal Adenocarcinoma: A Case Report with Key Imaging Findings and Radiologic-Pathologic Correlation. Case Rep Radiol, 2018:4935261. DOI: 10.1155/2018/4935261.